Model
Edge
Theravance Biopharma Inc.
TBPH
Filing type
8-K
Filing date
Sep 22, 2026
Updated
Sep 23, 2026 ยท 2:25 PM
Copy reference
Filing
8-K
Material Contracts, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
Exhibits
EX-3.1
EXHIBIT 3.1
EX-10.1
EXHIBIT 10.1
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events